These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 16886916)
1. Long-term reversal of hypocholesterolaemia in patients with chronic hepatitis C is related to sustained viral response and viral genotype. Fernández-Rodríguez CM; López-Serrano P; Alonso S; Gutiérrez ML; Lledó JL; Pérez-Calle JL; Temiño R; Cacho G; Nevado M; Casas ML; Gasalla JM; Bonet B Aliment Pharmacol Ther; 2006 Aug; 24(3):507-12. PubMed ID: 16886916 [TBL] [Abstract][Full Text] [Related]
2. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C. Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648 [TBL] [Abstract][Full Text] [Related]
3. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C. Liu CJ; Jeng YM; Chen PJ; Lai MY; Yang HC; Huang WL; Kao JH; Chen DS Antivir Ther; 2005; 10(3):405-15. PubMed ID: 15918331 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis C and steatosis: a reappraisal. Lonardo A; Loria P; Adinolfi LE; Carulli N; Ruggiero G J Viral Hepat; 2006 Feb; 13(2):73-80. PubMed ID: 16436124 [TBL] [Abstract][Full Text] [Related]
5. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection. Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519 [TBL] [Abstract][Full Text] [Related]
6. Serum leptin levels correlate with hepatic steatosis in chronic hepatitis C. Romero-Gómez M; Castellano-Megias VM; Grande L; Irles JA; Cruz M; Nogales MC; Alcón JC; Robles A Am J Gastroenterol; 2003 May; 98(5):1135-41. PubMed ID: 12809839 [TBL] [Abstract][Full Text] [Related]
7. Steatosis as a predictive factor for treatment response in patients with chronic hepatitis C. Antúnez I; Aponte N; Fernández-Carbia A; Rodríguez-Perez F; Toro DH P R Health Sci J; 2004 Jun; 23(2 Suppl):57-60. PubMed ID: 16929588 [TBL] [Abstract][Full Text] [Related]
8. Hepatic steatosis in genotype 4 chronic hepatitis C is mainly because of metabolic factors. Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Petraki K; Hadziyannis E; Pandelidaki H; Zafiropoulou R; Savvas S; Koskinas J; Archimandritis AJ Am J Gastroenterol; 2007 Mar; 102(3):634-41. PubMed ID: 17222326 [TBL] [Abstract][Full Text] [Related]
9. Hepatic steatosis in Iranian patients with chronic hepatitis C. Minakari M; Sameni FK; Shalmani HM; Molaee M; Zali MR Med Princ Pract; 2008; 17(2):126-30. PubMed ID: 18287796 [TBL] [Abstract][Full Text] [Related]
10. The relationship between serum adiponectin and steatosis in patients with chronic hepatitis C genotype-4. Ashour E; Samy N; Sayed M; Imam A Clin Lab; 2010; 56(3-4):103-10. PubMed ID: 20476641 [TBL] [Abstract][Full Text] [Related]
11. Daily cannabis use: a novel risk factor of steatosis severity in patients with chronic hepatitis C. Hézode C; Zafrani ES; Roudot-Thoraval F; Costentin C; Hessami A; Bouvier-Alias M; Medkour F; Pawlostky JM; Lotersztajn S; Mallat A Gastroenterology; 2008 Feb; 134(2):432-9. PubMed ID: 18242211 [TBL] [Abstract][Full Text] [Related]
13. Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C. Tsochatzis E; Papatheodoridis GV; Manesis EK; Chrysanthos N; Kafiri G; Archimandritis AJ Dig Liver Dis; 2007 Oct; 39(10):936-42. PubMed ID: 17720637 [TBL] [Abstract][Full Text] [Related]
14. Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. Sebastiani G; Vario A; Ferrari A; Pistis R; Noventa F; Alberti A J Viral Hepat; 2006 Mar; 13(3):199-205. PubMed ID: 16475996 [TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients. Durante-Mangoni E; Zampino R; Marrone A; Tripodi MF; Rinaldi L; Restivo L; Cioffi M; Ruggiero G; Adinolfi LE Aliment Pharmacol Ther; 2006 Nov; 24(9):1349-57. PubMed ID: 17059516 [TBL] [Abstract][Full Text] [Related]
16. Liver microsomal triglyceride transfer protein is involved in hepatitis C liver steatosis. Mirandola S; Realdon S; Iqbal J; Gerotto M; Dal Pero F; Bortoletto G; Marcolongo M; Vario A; Datz C; Hussain MM; Alberti A Gastroenterology; 2006 May; 130(6):1661-9. PubMed ID: 16697730 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus genotype 3 is cytopathic to hepatocytes: Reversal of hepatic steatosis after sustained therapeutic response. Kumar D; Farrell GC; Fung C; George J Hepatology; 2002 Nov; 36(5):1266-72. PubMed ID: 12395339 [TBL] [Abstract][Full Text] [Related]
19. Different mechanisms of steatosis in hepatitis C virus genotypes 1 and 3 infections. Hézode C; Roudot-Thoraval F; Zafrani ES; Dhumeaux D; Pawlotsky JM J Viral Hepat; 2004 Sep; 11(5):455-8. PubMed ID: 15357652 [TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus, diabetes and steatosis: clinical evidence in favor of a linkage and role of genotypes. Mihm S Dig Dis; 2010; 28(1):280-4. PubMed ID: 20460924 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]